间歇性禁食改善代谢综合征患者心血管代谢风险因素并改变肠道菌群
间歇性禁食显著减少脂肪量、改善氧化应激、调节炎症细胞因子和血管舒张参数,并改变肠道菌群组成与功能,增加短链脂肪酸产生、降低循环脂多糖。菌群变化与心血管风险因素改善显著相关。
要点
- 8周改良间歇性禁食可改善代谢综合征患者体脂、氧化应激、炎症及内皮功能。
- 间歇性禁食改变肠道菌群组成与功能,增加短链脂肪酸、降低循环脂多糖。
- 菌群改变与心血管风险因素改善显著相关,提示潜在机制关联。
核心结论
- 间歇性禁食显著改变肠道微生物群落及功能通路,且与心血管代谢风险因素的减轻密切相关。
研究设计与样本
- 干预为8周「2天」改良间歇性禁食。
主要发现
- 间歇性禁食组在禁食日较非禁食日减少69%热量摄入。
- 8周间歇性禁食显著减少脂肪量、改善氧化应激、调节炎症细胞因子并改善血管舒张参数。
- 间歇性禁食诱导肠道菌群群落显著变化,增加短链脂肪酸产生并降低循环脂多糖水平。
- 间歇性禁食相关的菌群改变与心血管风险因素显著相关,并导致肠道群落碳水化合物代谢的基因偏移。
临床怎么用
- 对代谢综合征成人,可考虑8周「2天」改良间歇性禁食作为改善心血管代谢风险因素的干预策略。
- 干预获益可能与肠道菌群及短链脂肪酸、脂多糖等代谢物改变相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Intermittent fasting (IF) is an effective strategy to improve cardiometabolic health. OBJECTIVE: The objective of this work is to examine the effects of IF on cardiometabolic risk factors and the gut microbiota in patients with metabolic syndrome (MS). DESIGN AND SETTING: A randomized clinical trial was conducted at a community health service center. PATIENTS: Participants included adults with MS, age 30 to 50 years. INTERVENTION: Intervention consisted of 8 weeks of "2-day" modified IF. MAIN OUTCOME MEASURE: Cardiometabolic risk factors including body composition, oxidative stress, inflammatory cytokines, and endothelial function were assessed at baseline and at 8 weeks. The diversity, composition, and functional pathways of the gut microbiota, as well as circulating gut-derived metabolites, were measured. RESULTS: Thirty-nine patients with MS were included: 21 in the IF group and 18 in the control group. On fasting days, participants in the IF group reduced 69% of their calorie intake compared to nonfasting days. The 8-week IF significantly reduced fat mass, ameliorated oxidative stress, modulated inflammatory cytokines, and improved vasodilatory parameters. Furthermore, IF induced significant changes in gut microbiota communities, increased the production of short-chain fatty acids, and decreased the circulating levels of lipopolysaccharides. The gut microbiota alteration attributed to the IF was significantly associated with cardiovascular risk factors and resulted in distinct genetic shifts of carbohydrate metabolism in the gut community. CONCLUSION: IF induces a significant alteration of the gut microbial community and functional pathways in a manner closely associated with the mitigation of cardiometabolic risk factors. The study provides potential mechanistic insights into the prevention of adverse outcomes associated with MS.
引用
- Guo Y, Luo S, Ye Y, et al. Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients. J Clin Endocrinol Metab. 2021. PMID: 33017844. doi:10.1210/clinem/dgaa644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。